Gastric Cancer Diagnostic Procedure Market Growth & Analysis 2028

Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Healthcare Provider (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Type (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedure (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], and Disease Indication (Early Gastric Cancer and Gastric Cancer Advanced Types)

Report Code : TIPRE00029842
Category : Life Sciences

Status : Published
No. of Pages : 398

Buy Now

The gastric cancer diagnostic procedure market is expected to grow from US$ 1307.96 million in 2022 to US$ 1912.03 million by 2028; it is estimated to register a CAGR of 6.5% from 2022 to 2028.

The gastric cancer diagnostic procedure market is segmented on the basis of healthcare provider, symptom type, body fluid, procedure, offering, disease indication, and geography. The report offers insights and in-depth analysis of the market, emphasizing parameters such as dynamics, trends, and opportunities in the gastric cancer diagnostic procedure market and competitive landscape analysis of leading market players across various regions. It also includes the impact analysis of COVID–19 pandemic on the market across these regions.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Gastric Cancer Diagnostic Procedure Market: Strategic Insights

Market Size Value in US$ 1307.96 million in 2022
Market Size Value by US$ 1912.03 million by 2028
Growth rate CAGR of 6.5% from 2022 to 2028
Forecast Period 2022-2028
Base Year 2022

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst

Market Insights

Rise in Prevalence of Gastrointestinal Diseases

Despite declining incidence and mortality during the last decades, stomach cancer is perceived as one of the main health challenges worldwide. According to the GLOBOCAN, stomach cancer caused ~800,000 deaths (accounting for 7.7% of all cancer-related deaths) in 2020. The disease ranks as the fourth leading cause of cancer deaths in both genders combined. ~1.1 million new cases of stomach cancer were diagnosed in 2020, accounting for 5.6% of all cancer cases. Asia accounts for ~75% of the new stomach cancer cases and deaths reported globally. Western countries, such as the US and Canada, report high GI disease incidence rates, which can be attributed to increasing obesity in the adult population and less consumption of dietary fibers. According to data released by the Centers for Disease Control and Prevention in December 2022, physicians’ offices in the US record ~37.2 million cases of digestive system diseases.

The prevalence of irritable bowel syndrome (IBS) has increased across the world in the last few decades. According to the International Foundation for Gastrointestinal Disorders, Inc., IBS is the most common functional GI disorder, with a global prevalence rate of 10–15%. Also, physicians in the US record ~2.4–3.5 million visits of IBS patients annually. Although the overall incidence rate of gastric cancer has been declining over the years, it has surged among young adults during the past several decades. Thus, the increasing prevalence of gastrointestinal (GI) disease results in a high risk of developing gastric cancer, which drives the growth of the gastric cancer diagnostic procedure market.

Healthcare Provider-Based Insights

The global gastric cancer diagnostic procedure market, based on healthcare provider, is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. In 2022, the hospitals segment held the largest share of the market. The market for the cancer research institutes segment is expected to grow at the highest CAGR during the forecast period.

Symptom Type-Based Insights

The gastric cancer diagnostic procedure market, by symptom type, is bifurcated into symptomatic and asymptomatic. In 2022, the asymptomatic segment held a larger market share. However, the symptomatic segment is estimated to register a higher CAGR during the forecast period.

Body Fluid-Based Insights

Based on body fluid, the gastric cancer diagnostic procedure market is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. In 2022, the blood segment held the largest market share. However, the market for the tissue segment is expected to grow at the fastest CAGR during the forecast period.

Procedure-Based Insights

Based on procedure, the gastric cancer diagnostic procedure market is segmented into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics and immunoassays, and others. In 2022, the imaging tests segment held the largest market share. The market for the biopsy and tissue tests segment is estimated to register a higher CAGR during the forecast period.

Offering-Based Insights

The gastric cancer diagnostic procedure market, based on offerings, is segmented into instruments, reagents and consumables, and services. In 2022, the reagents and consumables segment held the largest share of the market. The market for the services segment is estimated to register a higher CAGR during the forecast period.

Disease Indication-Based Insights

Based on disease indication, the gastric cancer diagnostic procedure market is segmented into early gastric cancer and advanced gastric cancer. In 2022, the advanced gastric cancer segment held a larger share of the market. The market for the same segment is expected to grow at a higher CAGR during the forecast period.

COVID-19 Insights

Preventive measures such as deliberately expanding the physical space to avoid close contacts and spread of illness, and mandating the use of masks in workplaces were implemented in several countries for reducing the spread of SARS-CoV-2. However, various restrictions resulted in the cancellation or rescheduling of appointments for gastric cancer diagnosis and treatments. According to a study published in 2021 in PubMed, significantly fewer patients were diagnosed with stage-I gastric and colorectal cancers during the COVID-19 phase. After the first quarter of 2020, the demand for gastric cancer diagnostics increased in the government and private institutions for testing COVID-19 patients for H. pylori infection. Furthermore, patients with advanced stages of gastric cancer were prioritized for diagnosis and treatment, which led to the gastric cancer diagnostic procedure market growth amid the COVID-19 crisis.

Gastric Cancer Diagnostic Procedure Market Report Scope

The gastric cancer diagnostic procedure market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand. Partnerships and collaborations are among the inorganic growth strategies witnessed in the market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence. Additionally, acquisitions, partnerships, and other growth strategies help companies to strengthen customer base and increase their product portfolios.

In February 2023, CARsgen Therapeutics announced a collaboration agreement with F. Hoffmann-La Roche (Roche) to assess AB011 and atezolizumab to treat gastric cancer. The collaboration will evaluate CARsgen’s investigational drug AB011, Roche’s PD-L1 checkpoint inhibitor atezolizumab, and the standard-of-care chemotherapy combination in gastric or gastroesophageal junction carcinoma patients.
In January 2023, Agilent Technologies announced a partnership with Akoya Biosciences to develop chromogenic and immunofluorescent multiplex assays that include spatial analysis for biopharma companies engaged in developing precision cancer therapeutics. This partnership enables an ecosystem that assists the development of novel precision cancer therapeutics and offers a streamlined workflow to the customers of both these companies in the clinical research market.
In August 2022, MiRXES launched a series of new capabilities—including an Industry 4.0 manufacturing facility, two new laboratories, and a collaborative multi-cancer screening research project. The new developments are aligned with MiRXES’ goal of advancing its research and production capabilities to develop miRNA-based disease detection tests.
In July 2022, MiRXES Pte Ltd launched the world’s first large-scale clinical research project—CADENCE (CAncer Detected Early caN be CurEd). The Project CADENCE aims to develop a multi-cancer early detection test for up to nine high-incidence and high-mortality cancers: lung, breast, colorectal, liver, stomach (gastric), esophageal, ovarian, pancreatic, and prostate cancers.

Gastric Cancer Diagnostic Procedure Market - Company Profiles

Atlas-Link Biotech Co Ltd
Bio-Rad Laboratories Inc
MiRXES Pte Ltd
Agilent Technologies Inc
F. Hoffmann-La Roche Ltd
bioMerieux SA
Thermo Fisher Scientific Inc
Illumina Inc
Vela Diagnostics Holding Pte Ltd
Myraid Genetics Inc

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Healthcare Provider, Symptom Type, Body Fluid, Procedure, Offering, and Disease Indication

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

Frequently Asked Questions

What are the driving factors for the global gastric cancer diagnostic procedure market across the world?

The factors that are driving the growth of the gastric cancer diagnostic procedure market are the rise in alcohol consumption, smoking, surging cases of Helicobacter pylori infection, and the rise in the prevalence of gastrointestinal diseases. These are some of the major factors contributing to the growth of the gastric cancer diagnostic procedure industry.

What is the gastric cancer diagnostic procedure?

Gastric cancer is a type of malignant cancer that forms the stomach's inner lining. Risk factors such as age, diet, and stomach diseases can lead to the development of gastric cancer. Symptoms of gastric cancer include indigestion, heartburn, bloating, and stomach discomfort or pain.

Who are the major players in the gastric cancer diagnostic procedure market across the globe?

The gastric cancer diagnostic procedure market majorly consists of the players, such as Atlas-Link Biotech Co Ltd, Bio-Rad Laboratories Inc, MiRXES Pte Ltd, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, bioMerieux SA, Thermo Fisher Scientific Inc, Illumina Inc, Vela Diagnostics Holding Pte Ltd, and Myraid Genetics Inc.

What is the estimated gastric cancer diagnostic procedure market size in 2022?

The gastric cancer diagnostic procedure market is estimated to be valued at US$ 1307.96 million in 2022.

What is the market CAGR value of the gastric cancer diagnostic procedure market during the forecast period?

The CAGR value of the gastric cancer diagnostic procedure market during the forecasted period is 6.5%%.

Which region is projected to be the fastest-growing region in the global gastric cancer diagnostic procedure market?

The Asia Pacific is expected to be the fastest-growing region in the gastric cancer diagnostic procedure market over the forecast period due to the increasing surging cases of helicobacter pylori infection and the rise in the prevalence of gastrointestinal diseases.

What are the growth estimates for the gastric cancer diagnostic procedure market till 2028?

The gastric cancer diagnostic procedure market is expected to be valued at US$ 1912.03 million by 2028.

Which segment by healthcare provider led the gastric cancer diagnostic procedure market?

The hospitals segment held the largest share of the market in 2022. Also, the cancer research institutes segment is estimated to register the highest CAGR in the market during the forecast period.

1. Introduction 66

1.1 Scope of the Study. 66

1.2 The Insight Partners Research Report Guidance. 66

1.3 Market Segmentation. 67

1.3.1 Global Gastric cancer diagnostic procedure Market – by Healthcare Providers. 68

1.3.2 Global Gastric Cancer Diagnostic Procedure Market – By Symptom Types. 69

1.3.3 Global Gastric Cancer Diagnostic Procedure Market – By Body Fluid. 69

1.3.4 Global Gastric Cancer Diagnostic Procedure Market – By Procedures. 69

1.3.5 Global Gastric Cancer Diagnostic Procedure Market – By Offerings. 70

1.3.6 Global Gastric Cancer Diagnostic Procedure Market – By Disease Indication. 70

1.3.7 Global Gastric cancer diagnostic procedure Market – by Geography. 70

2. Gastric Cancer Diagnostic Procedure Market – Key Takeaways 72

3. Research Methodology 78

3.1 Coverage. 79

3.2 Secondary Research. 79

3.3 Primary Research. 80

4. Gastric cancer diagnostic procedure Market – Market Landscape 81

4.1 Overview.. 81

4.2 PEST Analysis. 81

4.2.1 North America PEST Analysis. 81

4.2.2 Europe PEST Analysis. 82

4.2.3 Asia Pacific PEST Analysis. 82

4.2.4 South & Central America PEST Analysis. 83

4.2.5 Middle East & Africa PEST Analysis. 83

4.3 Expert’s Opinion. 84

5. Gastric Cancer Diagnostic Procedure Market – Key Market Dynamics 85

5.1 Market Drivers. 85

5.1.1 Rise in Prevalence of Gastrointestinal Diseases. 85

5.1.2 Surging Cases of Helicobacter Pylori Infection. 85

5.2 Market Restraints. 86

5.2.1 Shortage of Medical Laboratory Professionals. 86

5.3 Market Opportunities. 86

5.3.1 Rising Awareness of Gastric Cancer 86

5.4 Future Trends. 87

5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform... 87

5.5 Impact Analysis. 88

6. Gastric Cancer Diagnostic Procedure Market – Global Analysis 89

6.1 Global Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis. 89

6.2 Global Gastric Cancer Diagnostic Procedure Market, by Geography – Forecast and Analysis. 90

6.3 Market Positioning of Key Players. 91

6.4 Global Gastric Cancer Diagnostic Procedure Market – Market Potential Analysis, by Region. 91

6.5 Comparative Company Analysis. 92

6.6 Growth Strategy Analysis. 93

6.7 Performance of Key Players. 94

6.7.1 F. Hoffmann-La Roche Ltd. 94

6.7.2 Thermo Fisher Scientific Inc. 95

7. Global Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – by Healthcare Providers 96

7.1 Overview.. 96

7.2 Diagnostic Laboratories. 97

7.2.1 Overview.. 97

7.2.2 Diagnostic Laboratories: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 97

7.3 Hospitals. 98

7.3.1 Overview.. 98

7.3.2 Hospitals: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 98

7.4 Cancer Research Institutes. 99

7.4.1 Overview.. 99

7.4.2 Cancer Research Institutes: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 99

7.5 Oncology Specialty Clinics. 100

7.5.1 Overview.. 100

7.5.2 Oncology Specialty Clinics: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 100

7.6 Others. 101

7.6.1 Overview.. 101

7.6.2 Others: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 101

8. Global Gastric Cancer Diagnostic Procedure Market Analysis and Forecasts to 2028 – by Symptom Types 102

8.1 Overview.. 102

8.2 Symptomatic. 103

8.2.1 Overview.. 103

8.2.2 Symptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 103

8.3 Asymptomatic. 104

8.3.1 Overview.. 104

8.3.2 Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 104

9. Global Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – by Body Fluid 105

9.1 Overview.. 105

9.2 Blood. 106

9.2.1 Overview.. 106

9.2.2 Blood: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 106

9.3 Urine. 107

9.3.1 Overview.. 107

9.3.2 Urine: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 107

9.4 Saliva. 108

9.4.1 Overview.. 108

9.4.2 Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 108

9.5 Stomach Wash/Gastric Juice. 109

9.5.1 Overview.. 109

9.5.2 Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 109

9.6 Tissue. 110

9.6.1 Overview.. 110

9.6.2 Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 110

9.7 Others. 111

9.7.1 Overview.. 111

9.7.2 Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 111

10. Global Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – by Procedure 112

10.1 Overview.. 112

10.2 Endoscopic Procedure. 113

10.2.1 Overview.. 113

10.2.2 Endoscopic Procedure: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 113

10.3 Biopsy and Tissue Tests. 114

10.3.1 Overview.. 114

10.3.2 Biopsy and Tissue Tests: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 114

10.4 Lab Tests. 115

10.4.1 Overview.. 115

10.4.2 Lab Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 115

10.5 In-Vitro Diagnostic Tests. 116

10.5.1 Overview.. 116

10.5.2 In-Vitro Diagnostic Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 116

10.6 Imaging Tests. 117

10.6.1 Overview.. 117

10.6.2 Imaging Tests: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 117

10.7 Molecular Diagnostics. 118

10.7.1 Overview.. 118

10.7.2 Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 118

10.8 Multiplexing Molecular Diagnostics and Immunoassay. 119

10.8.1 Overview.. 119

10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 119

10.9 Others. 121

10.9.1 Overview.. 121

10.9.2 Others: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 121

11. Global Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – by Offerings 122

11.1 Overview.. 122

11.2 Instruments. 123

11.2.1 Overview.. 123

11.2.2 Instruments: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 123

11.3 Reagents and Consumables. 124

11.3.1 Overview.. 124

11.3.2 Reagents and Consumables: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 124

11.4 Services. 125

11.4.1 Overview.. 125

11.4.2 Services: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 125

12. Global Gastric Cancer Diagnostic Procedure Analysis – by Disease Indication 126

12.1 Overview.. 126

12.2 Early Gastric Cancer 127

12.2.1 Overview.. 127

12.2.2 Early Gastric Cancer: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 127

12.3 Gastric Cancer Advanced Types. 128

12.3.1 Overview.. 128

12.3.2 Gastric Cancer Advanced Types: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 128

13. Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – Geographic Analysis 129

13.1 North America: Gastric Cancer Diagnostic Procedure Market 129

13.1.1 Overview.. 129

13.1.2 North America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 130

13.1.3 North America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 130

13.1.3.1 North America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 131

13.1.3.2 North America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 131

13.1.3.3 North America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 131

13.1.3.4 North America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 132

13.1.4 North America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 132

13.1.5 North America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 133

13.1.6 North America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 133

13.1.6.1 North America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 134

13.1.6.2 North America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 134

13.1.6.3 North America: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 134

13.1.6.4 North America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 135

13.1.6.5 North America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 135

13.1.7 North America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 136

13.1.8 North America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 136

13.1.9 North America: Gastric Cancer Diagnostic Procedure Market, by Country. 137

13.1.9.1 US: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 137

13.1.9.1.1 Overview.. 137

13.1.9.1.2 United States: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 138

13.1.9.1.3 United States: Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 138

13.1.9.1.3.1 United States: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 139

13.1.9.1.3.2 United States: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 139

13.1.9.1.3.3 United States: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 140

13.1.9.1.3.4 United States: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 140

13.1.9.1.4 United States: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 140

13.1.9.1.5 United States: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 141

13.1.9.1.6 United States: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 141

13.1.9.1.6.1 United States: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 142

13.1.9.1.6.2 United States: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 142

13.1.9.1.6.3 United States: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 143

13.1.9.1.6.4 United States: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 143

13.1.9.1.6.5 United States: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 144

13.1.9.1.7 United States: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 144

13.1.9.1.8 United States: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 145

13.1.9.2 Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 146

13.1.9.2.1 Overview.. 146

13.1.9.2.2 Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 146

13.1.9.2.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 147

13.1.9.2.3.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 148

13.1.9.2.3.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 148

13.1.9.2.3.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 148

13.1.9.2.3.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 149

13.1.9.2.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 149

13.1.9.2.5 Canada: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 150

13.1.9.2.6 Canada: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 150

13.1.9.2.6.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 151

13.1.9.2.6.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 151

13.1.9.2.6.3 Canada: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 152

13.1.9.2.6.4 Canada Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 152

13.1.9.2.6.5 Canada Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 153

13.1.9.2.7 Canada Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 153

13.1.9.2.8 Canada Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 154

13.1.9.3 Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 155

13.1.9.3.1 Overview.. 155

13.1.9.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 155

13.1.9.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 156

13.1.9.3.3.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 156

13.1.9.3.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 157

13.1.9.3.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 157

13.1.9.3.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 157

13.1.9.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 158

13.1.9.3.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 158

13.1.9.3.6 Mexico: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 159

13.1.9.3.6.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 159

13.1.9.3.6.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 160

13.1.9.3.6.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 160

13.1.9.3.6.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 161

13.1.9.3.6.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 161

13.1.9.3.7 Mexico: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 162

13.1.9.3.8 Mexico: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 162

13.2 Europe: Gastric Cancer Diagnostic Procedure Market 163

13.2.1 Overview.. 163

13.2.2 Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 164

13.2.3 Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 164

13.2.3.1 Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 165

13.2.3.2 Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 165

13.2.3.3 Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 165

13.2.3.4 Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 166

13.2.4 Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 166

13.2.5 Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 166

13.2.6 Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 167

13.2.6.1 Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 167

13.2.6.2 Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 168

13.2.6.3 Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 168

13.2.6.4 Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 169

13.2.6.5 Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 169

13.2.7 Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 170

13.2.8 Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 170

13.2.9 Europe: Gastric Cancer Diagnostic Procedure Market, by Country. 171

13.2.9.1 Germany: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 171

13.2.9.1.1 Overview.. 171

13.2.9.1.2 Germany Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 172

13.2.9.1.3 Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 172

13.2.9.1.3.1 Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 173

13.2.9.1.3.2 Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 173

13.2.9.1.3.3 Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 173

13.2.9.1.3.4 Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 174

13.2.9.1.4 Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 174

13.2.9.1.5 Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 175

13.2.9.1.6 Germany Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 175

13.2.9.1.6.1 Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 176

13.2.9.1.6.2 Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 176

13.2.9.1.6.3 Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 177

13.2.9.1.6.4 Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 177

13.2.9.1.6.5 Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 178

13.2.9.1.7 Germany Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 178

13.2.9.1.8 Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 179

13.2.9.2 France: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 180

13.2.9.2.1 Overview.. 180

13.2.9.2.2 France: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million) 181

13.2.9.2.3 France: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million) 181

13.2.9.2.3.1 France: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 182

13.2.9.2.3.2 France: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 182

13.2.9.2.3.3 France: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 182

13.2.9.2.3.4 France: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 183

13.2.9.2.4 France: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 183

13.2.9.2.5 France: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 184

13.2.9.2.6 France: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 184

13.2.9.2.6.1 France: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 185

13.2.9.2.6.2 France: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 185

13.2.9.2.6.3 France: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 186

13.2.9.2.6.4 France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 186

13.2.9.2.6.5 France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 187

13.2.9.2.7 France Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 187

13.2.9.2.8 France Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 188

13.2.9.3 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 189

13.2.9.3.1 Overview.. 189

13.2.9.3.2 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 189

13.2.9.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 190

13.2.9.3.3.1 UK: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 191

13.2.9.3.3.2 UK: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 191

13.2.9.3.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 191

13.2.9.3.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 192

13.2.9.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 192

13.2.9.3.5 UK: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 192

13.2.9.3.6 UK: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 193

13.2.9.3.6.1 UK: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 193

13.2.9.3.6.2 UK: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 194

13.2.9.3.6.3 UK: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 194

13.2.9.3.6.4 UK: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 195

13.2.9.3.6.5 UK: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 195

13.2.9.3.7 UK: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 196

13.2.9.3.8 UK: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 196

13.2.9.4 Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 197

13.2.9.4.1 Overview.. 197

13.2.9.4.2 Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 197

13.2.9.4.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 198

13.2.9.4.3.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 198

13.2.9.4.3.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 199

13.2.9.4.3.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 199

13.2.9.4.3.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 199

13.2.9.4.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 200

13.2.9.4.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 200

13.2.9.4.6 Italy: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 201

13.2.9.4.6.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 201

13.2.9.4.6.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 202

13.2.9.4.6.3 Italy: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 202

13.2.9.4.6.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 203

13.2.9.4.6.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 203

13.2.9.4.7 Italy: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 204

13.2.9.4.8 Italy: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 204

13.2.9.5 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 205

13.2.9.5.1 Overview.. 205

13.2.9.5.2 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 205

13.2.9.5.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 206

13.2.9.5.3.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 206

13.2.9.5.3.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 206

13.2.9.5.3.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 207

13.2.9.5.3.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 207

13.2.9.5.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 208

13.2.9.5.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 208

13.2.9.5.6 Spain: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 209

13.2.9.5.6.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 209

13.2.9.5.6.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 210

13.2.9.5.6.3 Spain: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 210

13.2.9.5.6.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 211

13.2.9.5.6.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 211

13.2.9.5.7 Spain: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 212

13.2.9.5.8 Spain: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 212

13.2.9.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 213

13.2.9.6.1 Overview.. 213

13.2.9.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 213

13.2.9.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 214

13.2.9.6.3.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 214

13.2.9.6.3.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 215

13.2.9.6.3.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 215

13.2.9.6.3.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 215

13.2.9.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 216

13.2.9.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 216

13.2.9.6.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 217

13.2.9.6.6.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 217

13.2.9.6.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 218

13.2.9.6.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 218

13.2.9.6.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 219

13.2.9.6.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 219

13.2.9.6.7 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 220

13.2.9.6.8 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 220

13.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market 221

13.3.1 Overview.. 221

13.3.2 Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 222

13.3.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 222

13.3.3.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 223

13.3.3.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 223

13.3.3.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 223

13.3.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 224

13.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 224

13.3.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 225

13.3.6 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 225

13.3.6.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 226

13.3.6.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 226

13.3.6.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 226

13.3.6.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 227

13.3.6.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 227

13.3.7 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 228

13.3.8 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 228

13.3.9 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Country. 229

13.3.9.1 China: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 229

13.3.9.1.1 Overview.. 229

13.3.9.1.2 China Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 229

13.3.9.1.3 China Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 230

13.3.9.1.3.1 China Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 231

13.3.9.1.3.2 China Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 231

13.3.9.1.3.3 China Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 231

13.3.9.1.3.4 China Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 232

13.3.9.1.4 China Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 232

13.3.9.1.5 China Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 233

13.3.9.1.6 China Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 233

13.3.9.1.6.1 China Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 234

13.3.9.1.6.2 China Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 234

13.3.9.1.6.3 China Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 235

13.3.9.1.6.4 China Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 235

13.3.9.1.6.5 China Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 236

13.3.9.1.7 China Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 236

13.3.9.1.8 China Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 237

13.3.9.2 Japan: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 238

13.3.9.2.1 Overview.. 238

13.3.9.2.2 Japan: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million) 238

13.3.9.2.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million) 239

13.3.9.2.3.1 Japan: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 239

13.3.9.2.3.2 Japan: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 240

13.3.9.2.3.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 240

13.3.9.2.3.4 Japan: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 240

13.3.9.2.4 Japan: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 241

13.3.9.2.5 Japan: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 241

13.3.9.2.6 Japan: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 242

13.3.9.2.6.1 Japan: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 242

13.3.9.2.6.2 Japan: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 243

13.3.9.2.6.3 Japan: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 243

13.3.9.2.6.4 Japan Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 244

13.3.9.2.6.5 Japan Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 244

13.3.9.2.7 Japan Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 245

13.3.9.2.8 Japan Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 245

13.3.9.3 India: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 246

13.3.9.3.1 Overview.. 246

13.3.9.3.2 India: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 246

13.3.9.3.3 India: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 247

13.3.9.3.3.1 India: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 248

13.3.9.3.3.2 India: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 248

13.3.9.3.3.3 India: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 248

13.3.9.3.3.4 India: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 249

13.3.9.3.4 India: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 249

13.3.9.3.5 India: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 250

13.3.9.3.6 India: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 250

13.3.9.3.6.1 India: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 251

13.3.9.3.6.2 India: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 251

13.3.9.3.6.3 India: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 251

13.3.9.3.6.4 India: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 252

13.3.9.3.6.5 India: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 252

13.3.9.3.7 India: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 253

13.3.9.3.8 India: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 253

13.3.9.4 South Korea: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 254

13.3.9.4.1 Overview.. 254

13.3.9.4.2 South Korea: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 254

13.3.9.4.3 South Korea: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 255

13.3.9.4.3.1 South Korea: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 255

13.3.9.4.3.2 South Korea: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 256

13.3.9.4.3.3 South Korea: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 256

13.3.9.4.3.4 South Korea: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 256

13.3.9.4.4 South Korea: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 257

13.3.9.4.5 South Korea: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 257

13.3.9.4.6 South Korea: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 258

13.3.9.4.6.1 South Korea: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 258

13.3.9.4.6.2 South Korea: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 259

13.3.9.4.6.3 South Korea: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 259

13.3.9.4.6.4 South Korea: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 260

13.3.9.4.6.5 South Korea: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 260

13.3.9.4.7 South Korea: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 261

13.3.9.4.8 South Korea: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 261

13.3.9.5 Australia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 262

13.3.9.5.1 Overview.. 262

13.3.9.5.2 Australia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 262

13.3.9.5.3 Australia: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 263

13.3.9.5.3.1 Australia: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 263

13.3.9.5.3.2 Australia: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 263

13.3.9.5.3.3 Australia: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 264

13.3.9.5.3.4 Australia: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 264

13.3.9.5.4 Australia: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 265

13.3.9.5.5 Australia: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 265

13.3.9.5.6 Australia: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 266

13.3.9.5.6.1 Australia: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 266

13.3.9.5.6.2 Australia: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 267

13.3.9.5.6.3 Australia: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 267

13.3.9.5.6.4 Australia: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 268

13.3.9.5.6.5 Australia: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 268

13.3.9.5.7 Australia: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 269

13.3.9.5.8 Australia: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 269

13.3.9.6 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 270

13.3.9.6.1 Overview.. 270

13.3.9.6.2 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 270

13.3.9.6.3 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 271

13.3.9.6.3.1 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 271

13.3.9.6.3.2 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 272

13.3.9.6.3.3 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 272

13.3.9.6.3.4 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 272

13.3.9.6.4 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 273

13.3.9.6.5 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 273

13.3.9.6.6 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 274

13.3.9.6.6.1 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 274

13.3.9.6.6.2 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 275

13.3.9.6.6.3 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 275

13.3.9.6.6.4 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 276

13.3.9.6.6.5 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 276

13.3.9.6.7 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 277

13.3.9.6.8 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 277

13.4 South & Central America: Gastric Cancer Diagnostic Procedure Market 278

13.4.1 Overview.. 278

13.4.2 South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 279

13.4.3 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 279

13.4.3.1 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 280

13.4.3.2 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 280

13.4.3.3 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 280

13.4.3.4 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 281

13.4.4 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 281

13.4.5 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 282

13.4.6 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 282

13.4.6.1 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 283

13.4.6.2 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 283

13.4.6.3 South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 284

13.4.6.4 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 284

13.4.6.5 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 285

13.4.7 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 285

13.4.8 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 286

13.4.9 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country. 286

13.4.9.1 Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 287

13.4.9.1.1 Overview.. 287

13.4.9.1.2 Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 287

13.4.9.1.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 288

13.4.9.1.3.1 Brazil: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 288

13.4.9.1.3.2 Brazil: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 289

13.4.9.1.3.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 289

13.4.9.1.3.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 289

13.4.9.1.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 290

13.4.9.1.5 Brazil: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 290

13.4.9.1.6 Brazil: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 291

13.4.9.1.6.1 Brazil: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 291

13.4.9.1.6.2 Brazil: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 292

13.4.9.1.6.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 292

13.4.9.1.6.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 293

13.4.9.1.6.5 Brazil: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 293

13.4.9.1.7 Brazil: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 294

13.4.9.1.8 Brazil: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 294

13.4.9.2 Argentina: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 295

13.4.9.2.1 Overview.. 295

13.4.9.2.2 Argentina: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million) 295

13.4.9.2.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 296

13.4.9.2.3.1 Argentina: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 296

13.4.9.2.3.2 Argentina: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 297

13.4.9.2.3.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 297

13.4.9.2.3.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 297

13.4.9.2.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 298

13.4.9.2.5 Argentina: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 298

13.4.9.2.6 Argentina: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 299

13.4.9.2.6.1 Argentina: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 299

13.4.9.2.6.2 Argentina: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 300

13.4.9.2.6.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 300

13.4.9.2.6.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 301

13.4.9.2.6.5 Argentina: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 301

13.4.9.2.7 Argentina: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 302

13.4.9.2.8 Argentina: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 302

13.4.9.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 303

13.4.9.3.1 Overview.. 303

13.4.9.3.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 303

13.4.9.3.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 304

13.4.9.3.3.1 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 305

13.4.9.3.3.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 305

13.4.9.3.3.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 305

13.4.9.3.3.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 306

13.4.9.3.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 306

13.4.9.3.5 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 307

13.4.9.3.6 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 307

13.4.9.3.6.1 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 308

13.4.9.3.6.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 308

13.4.9.3.6.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 309

13.4.9.3.6.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 309

13.4.9.3.6.5 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 310

13.4.9.3.7 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 310

13.4.9.3.8 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 311

13.5 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market 312

13.5.1 Overview.. 312

13.5.2 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 313

13.5.3 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 313

13.5.3.1 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 314

13.5.3.2 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 314

13.5.3.3 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 314

13.5.3.4 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 315

13.5.4 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 315

13.5.5 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 316

13.5.6 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 316

13.5.6.1 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 317

13.5.6.2 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 317

13.5.6.3 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 318

13.5.6.4 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 318

13.5.6.5 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 319

13.5.7 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 319

13.5.8 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 320

13.5.9 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Country. 320

13.5.9.1 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 321

13.5.9.1.1 Overview.. 321

13.5.9.1.2 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 321

13.5.9.1.3 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 322

13.5.9.1.3.1 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 322

13.5.9.1.3.2 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 323

13.5.9.1.3.3 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 323

13.5.9.1.3.4 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 323

13.5.9.1.4 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 324

13.5.9.1.5 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 324

13.5.9.1.6 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 325

13.5.9.1.6.1 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 325

13.5.9.1.6.2 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 326

13.5.9.1.6.3 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 326

13.5.9.1.6.4 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 327

13.5.9.1.6.5 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 327

13.5.9.1.7 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 328

13.5.9.1.8 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 328

13.5.9.2 South Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 329

13.5.9.2.1 Overview.. 329

13.5.9.2.2 South Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 329

13.5.9.2.3 South Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 330

13.5.9.2.3.1 South Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 330

13.5.9.2.3.2 South Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 331

13.5.9.2.3.3 South Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 331

13.5.9.2.3.4 South Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 331

13.5.9.2.4 South Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 332

13.5.9.2.5 South Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 332

13.5.9.2.6 South Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 333

13.5.9.2.6.1 South Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 333

13.5.9.2.6.2 South Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 334

13.5.9.2.6.3 South Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 334

13.5.9.2.6.4 South Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 335

13.5.9.2.6.5 South Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 335

13.5.9.2.7 South Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 336

13.5.9.2.8 South Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 336

13.5.9.3 UAE: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 337

13.5.9.3.1 Overview.. 337

13.5.9.3.2 UAE: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 337

13.5.9.3.3 UAE: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 338

13.5.9.3.3.1 UAE: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 338

13.5.9.3.3.2 UAE: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 338

13.5.9.3.3.3 UAE: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 339

13.5.9.3.3.4 UAE: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 339

13.5.9.3.4 UAE: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 340

13.5.9.3.5 UAE: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 340

13.5.9.3.6 UAE: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 341

13.5.9.3.6.1 UAE: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 341

13.5.9.3.6.2 UAE: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 342

13.5.9.3.6.3 UAE: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 342

13.5.9.3.6.4 UAE: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 343

13.5.9.3.6.5 UAE: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 343

13.5.9.3.7 UAE: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 344

13.5.9.3.8 UAE: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 344

13.5.9.4 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 345

13.5.9.4.1 Overview.. 345

13.5.9.4.2 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 345

13.5.9.4.3 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 346

13.5.9.4.3.1 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 346

13.5.9.4.3.2 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 347

13.5.9.4.3.3 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 347

13.5.9.4.3.4 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 347

13.5.9.4.4 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 348

13.5.9.4.5 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 348

13.5.9.4.6 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 349

13.5.9.4.6.1 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 349

13.5.9.4.6.2 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 350

13.5.9.4.6.3 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 350

13.5.9.4.6.4 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 351

13.5.9.4.6.5 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 351

13.5.9.4.7 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 352

13.5.9.4.8 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 352

14. Impact Of COVID-19 Pandemic on Gastric Cancer Diagnostic Procedure Market 353

14.1 North America: Impact Assessment of COVID-19 Pandemic. 353

14.2 Europe: Impact Assessment of COVID-19 Pandemic. 354

14.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic. 356

14.4 South & Central America: Impact Assessment of COVID-19 Pandemic. 358

14.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic. 359

15. Gastric Cancer Diagnostic Procedure Market – Industry Landscape 361

15.1 Overview.. 361

15.2 Growth Strategies Done by the Companies in the Market, (%) 361

15.3 Organic Developments. 362

15.3.1 Overview.. 362

15.4 Inorganic Developments. 363

15.4.1 Overview.. 363

16. Company Profiles 364

16.1 Atlas-Link Biotech Co Ltd. 364

16.1.1 Key Facts. 364

16.1.2 Business Description. 364

16.1.3 Products and Services. 364

16.1.4 Financial Overview.. 364

16.1.5 SWOT Analysis. 365

16.1.6 Key Developments. 365

16.2 Bio-Rad Laboratories Inc. 366

16.2.1 Key Facts. 366

16.2.2 Business Description. 366

16.2.3 Products and Services. 366

16.2.4 Financial Overview.. 367

16.2.5 SWOT Analysis. 368

16.2.6 Key Developments. 368

16.3 MiRXES Pte Ltd. 369

16.3.1 Key Facts. 369

16.3.2 Business Description. 369

16.3.3 Products and Services. 369

16.3.4 Financial Overview.. 369

16.3.5 SWOT Analysis. 370

16.3.6 Key Developments. 370

16.4 Agilent Technologies Inc. 371

16.4.1 Key Facts. 371

16.4.2 Business Description. 371

16.4.3 Products and Services. 371

16.4.4 Financial Overview.. 372

16.4.5 SWOT Analysis. 373

16.4.6 Key Developments. 374

16.5 F. Hoffmann-La Roche Ltd. 375

16.5.1 Key Facts. 375

16.5.2 Business Description. 375

16.5.3 Products and Services. 376

16.5.4 Financial Overview.. 376

16.5.5 SWOT Analysis. 378

16.5.6 Key Developments. 378

16.6 bioMerieux SA. 379

16.6.1 Key Facts. 379

16.6.2 Business Description. 379

16.6.3 Products and Services. 379

16.6.4 Financial Overview.. 380

16.6.5 SWOT Analysis. 381

16.6.6 Key Developments. 381

16.7 Thermo Fisher Scientific Inc. 382

16.7.1 Key Facts. 382

16.7.2 Business Description. 382

16.7.3 Products and Services. 383

16.7.4 Financial Overview.. 384

16.7.5 SWOT Analysis. 385

16.7.6 Key Developments. 386

16.8 Illumina Inc. 387

16.8.1 Key Facts. 387

16.8.2 Business Description. 387

16.8.3 Products and Services. 387

16.8.4 Financial Overview.. 388

16.8.5 SWOT Analysis. 389

16.8.6 Key Developments. 390

16.9 Vela Diagnostics Holding Pte Ltd. 391

16.9.1 Key Facts. 391

16.9.2 Business Description. 391

16.9.3 Products and Services. 391

16.9.4 Financial Overview.. 392

16.9.5 SWOT Analysis. 392

16.9.6 Key Developments. 392

16.10 Myraid Genetics Inc. 393

16.10.1 Key Facts. 393

16.10.2 Business Description. 393

16.10.3 Products and Services. 393

16.10.4 Financial Overview.. 394

16.10.5 SWOT Analysis. 395

16.10.6 Key Developments. 395

17. Appendix 396

17.1 About The Insight Partners. 396

17.2 Glossary of Terms. 396

LIST OF TABLES

Table 1. North America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 130

Table 2. North America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 131

Table 3. North America: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 131

Table 4. North America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 131

Table 5. North America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 132

Table 6. North America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 132

Table 7. North America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 133

Table 8. North America: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 133

Table 9. North America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 134

Table 10. North America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 134

Table 11. North America: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 134

Table 12. North America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 135

Table 13. North America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 135

Table 14. North America: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 136

Table 15. North America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 136

Table 16. United States: Gastric cancer diagnostic procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 138

Table 17. United States: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 139

Table 18. United States: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 139

Table 19. United States: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 140

Table 20. United States: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 140

Table 21. United States: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 140

Table 22. United States: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 141

Table 23. United States: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 141

Table 24. United States: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 142

Table 25. United States: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 142

Table 26. United States: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 143

Table 27. United States: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 143

Table 28. United States: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 144

Table 29. United States: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 144

Table 30. United States: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 145

Table 31. Canada Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 147

Table 32. Canada Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 148

Table 33. Canada Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 148

Table 34. Canada Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 148

Table 35. Canada Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 149

Table 36. Canada Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 149

Table 37. Canada Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 150

Table 38. Canada Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 150

Table 39. Canada Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 151

Table 40. Canada Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 151

Table 41. Canada Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 152

Table 42. Canada Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 152

Table 43. Canada Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 153

Table 44. Canada Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 153

Table 45. Canada Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 154

Table 46. Mexico Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 156

Table 47. Mexico Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 156

Table 48. Mexico Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 157

Table 49. Mexico Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 157

Table 50. Mexico Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 157

Table 51. Mexico Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 158

Table 52. Mexico Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 158

Table 53. Mexico Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 159

Table 54. Mexico Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 159

Table 55. Mexico Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 160

Table 56. Mexico Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 160

Table 57. Mexico Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 161

Table 58. Mexico Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 161

Table 59. Mexico Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 162

Table 60. Mexico Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 162

Table 61. Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 164

Table 62. Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 165

Table 63. Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 165

Table 64. Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 165

Table 65. Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 166

Table 66. Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 166

Table 67. Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 166

Table 68. Europe Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 167

Table 69. Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 167

Table 70. Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 168

Table 71. Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 168

Table 72. Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 169

Table 73. Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 169

Table 74. Europe Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 170

Table 75. Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 170

Table 76. Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 172

Table 77. Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 173

Table 78. Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 173

Table 79. Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 173

Table 80. Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 174

Table 81. Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 174

Table 82. Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 175

Table 83. Germany Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 175

Table 84. Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 176

Table 85. Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 176

Table 86. Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 177

Table 87. Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 177

Table 88. Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 178

Table 89. Germany Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 178

Table 90. Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 179

Table 91. France Gastric Cancer Diagnostic Procedure Market, by Healthcare providers – Revenue and Forecast to 2028 (US$ Million) 181

Table 92. France Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 182

Table 93. France Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 182

Table 94. France Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 182

Table 95. France Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 183

Table 96. France Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 183

Table 97. France Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 184

Table 98. France Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 184

Table 99. France Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 185

Table 100. France Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 185

Table 101. France Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 186

Table 102. France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 186

Table 103. France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 187

Table 104. France Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 187

Table 105. France Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 188

Table 106. UK Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 190

Table 107. UK Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 191

Table 108. UK Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 191

Table 109. UK Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 191

Table 110. UK Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 192

Table 111. UK Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 192

Table 112. UK Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 192

Table 113. UK Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 193

Table 114. UK Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 193

Table 115. UK Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 194

Table 116. UK Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 194

Table 117. UK Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 195

Table 118. UK Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 195

Table 119. UK Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 196

Table 120. UK Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 196

Table 121. Italy Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 198

Table 122. Italy Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 198

Table 123. Italy Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 199

Table 124. Italy Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 199

Table 125. Italy Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 199

Table 126. Italy Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 200

Table 127. Italy Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 200

Table 128. Italy Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 201

Table 129. Italy Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 201

Table 130. Italy Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 202

Table 131. Italy Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 202

Table 132. Italy Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 203

Table 133. Italy Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 203

Table 134. Italy Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 204

Table 135. Italy Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 204

Table 136. Spain Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 206

Table 137. Spain Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 206

Table 138. Spain Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 206

Table 139. Spain Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 207

Table 140. Spain Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 207

Table 141. Spain Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 208

Table 142. Spain Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 208

Table 143. Spain Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 209

Table 144. Spain Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 209

Table 145. Spain Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 210

Table 146. Spain Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 210

Table 147. Spain Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 211

Table 148. Spain Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 211

Table 149. Spain Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 212

Table 150. Spain Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 212

Table 151. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 214

Table 152. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 214

Table 153. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 215

Table 154. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 215

Table 155. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 215

Table 156. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 216

Table 157. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 216

Table 158. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 217

Table 159. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 217

Table 160. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 218

Table 161. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 218

Table 162. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 219

Table 163. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 219

Table 164. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 220

Table 165. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 220

Table 166. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 222

Table 167. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 223

Table 168. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 223

Table 169. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 223

Table 170. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 224

Table 171. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 224

Table 172. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 225

Table 173. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 225

Table 174. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 226

Table 175. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 226

Table 176. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 226

Table 177. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 227

Table 178. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 227

Table 179. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 228

Table 180. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 228

Table 181. China Gastric cancer diagnostic procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 230

Table 182. China Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 231

Table 183. China Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 231

Table 184. China Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 231

Table 185. China Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 232

Table 186. China Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 232

Table 187. China Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 233

Table 188. China Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 233

Table 189. China Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 234

Table 190. China Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 234

Table 191. China Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 235

Table 192. China Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 235

Table 193. China Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 236

Table 194. China Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 236

Table 195. China Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 237

Table 196. Japan Gastric Cancer Diagnostic Procedure Market, by Healthcare providers – Revenue and Forecast to 2028 (US$ Million) 239

Table 197. Japan Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 239

Table 198. Japan Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 240

Table 199. Japan Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 240

Table 200. Japan Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 240

Table 201. Japan Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 241

Table 202. Japan Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 241

Table 203. Japan Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 242

Table 204. Japan Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 242

Table 205. Japan Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 243

Table 206. Japan Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 243

Table 207. Japan Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 244

Table 208. Japan Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 244

Table 209. Japan Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 245

Table 210. Japan Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 245

Table 211. India Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 247

Table 212. India Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 248

Table 213. India Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 248

Table 214. India Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 248

Table 215. India Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 249

Table 216. India Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 249

Table 217. India Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 250

Table 218. India Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 250

Table 219. India Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 251

Table 220. India Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 251

Table 221. India Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 251

Table 222. India Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 252

Table 223. India Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 252

Table 224. India Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 253

Table 225. India Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 253

Table 226. South Korea Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 255

Table 227. South Korea Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 255

Table 228. South Korea Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 256

Table 229. South Korea Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 256

Table 230. South Korea Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 256

Table 231. South Korea Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 257

Table 232. South Korea Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 257

Table 233. South Korea Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 258

Table 234. South Korea Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 258

Table 235. South Korea Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 259

Table 236. South Korea Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 259

Table 237. South Korea Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 260

Table 238. South Korea Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 260

Table 239. South Korea Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 261

Table 240. South Korea Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 261

Table 241. Australia Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 263

Table 242. Australia Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 263

Table 243. Australia Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 263

Table 244. Australia Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 264

Table 245. Australia Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 264

Table 246. Australia Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 265

Table 247. Australia Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 265

Table 248. Australia Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 266

Table 249. Australia Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 266

Table 250. Australia Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 267

Table 251. Australia Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 267

Table 252. Australia Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 268

Table 253. Australia Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 268

Table 254. Australia Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 269

Table 255. Australia Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 269

Table 256. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 271

Table 257. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 271

Table 258. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 272

Table 259. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 272

Table 260. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 272

Table 261. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 273

Table 262. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 273

Table 263. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 274

Table 264. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 274

Table 265. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 275

Table 266. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 275

Table 267. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 276

Table 268. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 276

Table 269. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 277

Table 270. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 277

Table 271. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 279

Table 272. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 280

Table 273. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 280

Table 274. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 280

Table 275. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 281

Table 276. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 281

Table 277. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 282

Table 278. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 282

Table 279. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 283

Table 280. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 283

Table 281. South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 284

Table 282. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 284

Table 283. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 285

Table 284. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 285

Table 285. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 286

Table 286. Brazil: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 288

Table 287. Brazil: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 288

Table 288. Brazil: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 289

Table 289. Brazil: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 289

Table 290. Brazil: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 289

Table 291. Brazil: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 290

Table 292. Brazil: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 290

Table 293. Brazil: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 291

Table 294. Brazil: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 291

Table 295. Brazil: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 292

Table 296. Brazil: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 292

Table 297. Brazil: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 293

Table 298. Brazil: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 293

Table 299. Brazil: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 294

Table 300. Brazil: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 294

Table 301. Argentina: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 296

Table 302. Argentina: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 296

Table 303. Argentina: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 297

Table 304. Argentina: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 297

Table 305. Argentina: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 297

Table 306. Argentina: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 298

Table 307. Argentina: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 298

Table 308. Argentina: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 299

Table 309. Argentina: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 299

Table 310. Argentina: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 300

Table 311. Argentina: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 300

Table 312. Argentina: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 301

Table 313. Argentina: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 301

Table 314. Argentina: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 302

Table 315. Argentina: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 302

Table 316. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 304

Table 317. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 305

Table 318. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 305

Table 319. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 305

Table 320. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 306

Table 321. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 306

Table 322. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 307

Table 323. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 307

Table 324. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 308

Table 325. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 308

Table 326. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 309

Table 327. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 309

Table 328. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 310

Table 329. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 310

Table 330. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 311

Table 331. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 313

Table 332. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 314

Table 333. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 314

Table 334. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 314

Table 335. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 315

Table 336. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 315

Table 337. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 316

Table 338. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 316

Table 339. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 317

Table 340. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 317

Table 341. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 318

Table 342. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 318

Table 343. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 319

Table 344. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 319

Table 345. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 320

Table 346. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 322

Table 347. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 322

Table 348. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 323

Table 349. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 323

Table 350. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 323

Table 351. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 324

Table 352. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 324

Table 353. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 325

Table 354. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 325

Table 355. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 326

Table 356. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 326

Table 357. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 327

Table 358. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 327

Table 359. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 328

Table 360. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 328

Table 361. South Africa Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 330

Table 362. South Africa Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 330

Table 363. South Africa Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 331

Table 364. South Africa Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 331

Table 365. South Africa Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 331

Table 366. South Africa Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 332

Table 367. South Africa Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 332

Table 368. South Africa Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 333

Table 369. South Africa Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 333

Table 370. South Africa Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 334

Table 371. South Africa Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 334

Table 372. South Africa Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 335

Table 373. South Africa Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 335

Table 374. South Africa Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 336

Table 375. South Africa Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 336

Table 376. UAE Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 338

Table 377. UAE Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 338

Table 378. UAE Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 338

Table 379. UAE Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 339

Table 380. UAE Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 339

Table 381. UAE Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 340

Table 382. UAE Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 340

Table 383. UAE Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 341

Table 384. UAE Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 341

Table 385. UAE Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 342

Table 386. UAE Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 342

Table 387. UAE Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 343

Table 388. UAE Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 343

Table 389. UAE Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 344

Table 390. UAE Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 344

Table 391. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 346

Table 392. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 346

Table 393. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 347

Table 394. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 347

Table 395. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 347

Table 396. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 348

Table 397. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 348

Table 398. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 349

Table 399. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 349

Table 400. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 350

Table 401. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 350

Table 402. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 351

Table 403. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 351

Table 404. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 352

Table 405. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 352

Table 406. Organic Developments Done by Companies. 362

Table 407. Inorganic Developments Done by Companies. 363

Table 408. Glossary of Terms. 396

LIST OF FIGURES

Figure 1. Gastric Cancer Diagnostic Procedure Market Segmentation. 67

Figure 2. Gastric Cancer Diagnostic Procedure Market, by Region. 68

Figure 3. Global Gastric Cancer Diagnostic Procedure Market Overview.. 72

Figure 4. Asymptomatic Segment Held a Larger Share From Symptom Type Segment in Gastric Cancer Diagnostic Procedure Market 73

Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period. 74

Figure 6. Gastric Cancer Diagnostic Procedure Market, by Geography (US$ Million) 75

Figure 7. Global Gastric Cancer Diagnostic Procedure Market – Leading Country Markets (US$ Million) 76

Figure 8. Global Gastric Cancer Diagnostic Procedure Market – Industry Landscape. 77

Figure 9. North America: PEST Analysis. 81

Figure 10. Europe: PEST Analysis. 82

Figure 11. Asia Pacific: PEST Analysis. 82

Figure 12. South & Central America: PEST Analysis. 83

Figure 13. Middle East & Africa: PEST Analysis. 83

Figure 14. Experts’ Opinion. 84

Figure 15. Gastric Cancer Diagnostic Procedure Market: Impact Analysis of Drivers and Restraints. 88

Figure 16. Global Gastric Cancer Diagnostic Procedure Market – Revenue Forecast and Analysis – 2020–2028. 89

Figure 17. Global Gastric Cancer Diagnostic Procedure Market, by Geography – Forecast and Analysis (2020–2028) 90

Figure 18. Market Positioning of Key Players in Gastric Cancer Diagnostic Procedure Market 91

Figure 19. Global Gastric Cancer Diagnostic Procedure Market – Market Potential Analysis, by Region. 91

Figure 20. Global Gastric Cancer Diagnostic Procedure Market – Comparative Company Analysis. 92

Figure 21. Global Gastric Cancer Diagnostic Procedure Market – Growth Strategy Analysis. 93

Figure 22. Global Gastric Cancer Diagnostic Procedure, by Healthcare Providers, 2021 & 2028 (%) 96

Figure 23. Diagnostic Laboratories: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 97

Figure 24. Hospitals: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 98

Figure 25. Cancer Research Institutes: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 99

Figure 26. Oncology Specialty Clinics: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 100

Figure 27. Others: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 101

Figure 28. Global Gastric Cancer Diagnostic Procedure, by Symptom Type, 2021 & 2028 (%) 102

Figure 29. Symptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 103

Figure 30. Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 104

Figure 31. Global Gastric Cancer Diagnostic Procedure, by Body Fluid, 2021 & 2028 (%) 105

Figure 32. Blood: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 106

Figure 33. Urine: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 107

Figure 34. Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 108

Figure 35. Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 109

Figure 36. Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 110

Figure 37. Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 111

Figure 38. Global Gastric Cancer Diagnostic Procedure, by Procedures, 2021 & 2028 (%) 112

Figure 39. Endoscopic Procedure: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 113

Figure 40. Biopsy and Tissue Tests: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 114

Figure 41. Lab Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 115

Figure 42. In-Vitro Diagnostic Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 116

Figure 43. Imaging Tests: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 117

Figure 44. Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 118

Figure 45. Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 120

Figure 46. Others: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 121

Figure 47. Global Gastric Cancer Diagnostic Procedure, by Offerings, 2021 & 2028 (%) 122

Figure 48. Instruments: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 123

Figure 49. Reagents and Consumables: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 124

Figure 50. Services: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 125

Figure 51. Global Gastric Cancer Diagnostic Procedure, by Disease Indication, 2021 & 2028 (%) 126

Figure 52. Early Gastric Cancer: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 127

Figure 53. Gastric Cancer Advanced Types: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 128

Figure 54. North America: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 129

Figure 55. North America Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 130

Figure 56. North America: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 137

Figure 57. United States: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 138

Figure 58. Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 147

Figure 59. Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 155

Figure 60. Europe: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 163

Figure 61. Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 164

Figure 62. Europe: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 171

Figure 63. Germany Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 172

Figure 64. France: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 181

Figure 65. UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 190

Figure 66. Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 197

Figure 67. Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 205

Figure 68. Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 213

Figure 69. Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 221

Figure 70. Asia Pacific Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 222

Figure 71. Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 229

Figure 72. China Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 230

Figure 73. Japan: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 238

Figure 74. India: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 247

Figure 75. South Korea: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 254

Figure 76. Australia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 262

Figure 77. Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 270

Figure 78. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 278

Figure 79. South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 279

Figure 80. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 286

Figure 81. Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 287

Figure 82. Argentina: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 295

Figure 83. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 304

Figure 84. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 312

Figure 85. Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 313

Figure 86. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 320

Figure 87. Saudi Arabia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 321

Figure 88. South Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 329

Figure 89. UAE: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 337

Figure 90. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 345

Figure 91. Impact of COVID-19 Pandemic on North American Country Markets. 353

Figure 92. Impact of COVID-19 Pandemic in European Country Markets. 355

Figure 93. Impact of COVID-19 Pandemic on Asia Pacific Country Markets. 357

Figure 94. Impact of COVID-19 Pandemic on South & Central American Country Markets. 359

Figure 95. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets. 360

Figure 96. Growth Strategies Done by the Companies in the Market, (%) 361

The List of Companies - Gastric Cancer Diagnostic Procedure Market

Atlas-Link Biotech Co Ltd
Bio-Rad Laboratories Inc
MiRXES Pte Ltd
Agilent Technologies Inc
F. Hoffmann-La Roche Ltd
bioMerieux SA
Thermo Fisher Scientific Inc
Illumina Inc
Vela Diagnostics Holding Pte Ltd
Myraid Genetics Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Gastric Cancer Diagnostic Procedure Market

Feb 2023

Laser-Assisted ENT Surgeries Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)

[read more] GET SAMPLE

Feb 2023

Mobile Cleanroom Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography

[read more] GET SAMPLE

Feb 2023

Ovo-Sexing Technology Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)

[read more] GET SAMPLE

Feb 2023

Dental Laser Treatment Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography

[read more] GET SAMPLE

Feb 2023

Microbiology CRO Services Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography

[read more] GET SAMPLE

Feb 2023

Antimicrobial Surgical Suture Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

[read more] GET SAMPLE

Feb 2023

Fall Management Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography

[read more] GET SAMPLE

Feb 2023

Organoids Services Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

[read more] GET SAMPLE

Market Size Value in	US$ 1307.96 million in 2022
Market Size Value by	US$ 1912.03 million by 2028
Growth rate	CAGR of 6.5% from 2022 to 2028
Forecast Period	2022-2028
Base Year	2022